Therapeutic potential of wavelength-dependent photobiomodulation on gut inflammation in an in vitro intestinal model.

Fuente: PubMed
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kang, Myungji, Jo, Jihye, Shin, Hwarang, Kang, Hyun Wook
Format: Artículo científico
Sprache:en
Veröffentlicht: Journal of photochemistry and photobiology. B, Biology 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1868266188981665793
author Kang, Myungji
Jo, Jihye
Shin, Hwarang
Kang, Hyun Wook
author_facet Kang, Myungji
Jo, Jihye
Shin, Hwarang
Kang, Hyun Wook
Kang, Myungji
Jo, Jihye
Shin, Hwarang
Kang, Hyun Wook
collection PubMed - marine biology
contents Therapeutic potential of wavelength-dependent photobiomodulation on gut inflammation in an in vitro intestinal model. Kang, Myungji Jo, Jihye Shin, Hwarang Kang, Hyun Wook Humans Caco-2 Cells Low-Level Light Therapy Lipopolysaccharides Inflammation Cytokines NF-kappa B Nitric Oxide Lactobacillus Coculture Techniques Intestines Gastrointestinal Microbiome Nitric Oxide Synthase Type II Recently, photobiomodulation (PBM) has emerged as a novel therapeutic approach for modulating the gut microbiome, offering potential for the regulation of intestinal inflammation. Although PBM has been primarily used for various clinical applications, recent studies suggest that its effects may extend to the regulation of microbial imbalances and chronic inflammation. The biological effects of PBM are wavelength-dependent, as the wavelength of light determines tissue penetration depth and cellular response. The current study aimed to compare the inflammation-modulatory effects of PBM at four different wavelengths (405, 532, 635, and 808 nm) and to elucidate the underlying molecular mechanisms of PBM in intestinal inflammation. An in vitro co-culture model consisting of Caco-2 cells and Lactobacillus was established to simulate the intestinal environment. Cellular inflammation was induced by lipopolysaccharide (LPS) stimulation, followed by wavelength-dependent PBM treatment at a dosage of 10 J/cm (100 mW/cm for 100 s, applied as a single irradiation). Among the wavelengths, 635 nm significantly reduced nitric oxide production and suppressed the expression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, and iNOS). Furthermore, western blot and qPCR analyses revealed that 635 nm PBM downregulated key signaling factors in the MAPK/NF-kB pathway, indicating a potential molecular mechanism for its anti-inflammatory effect. These findings suggest that PBM, particularly at 635 nm, may serve as an effective strategy for modulating intestinal inflammation. Further studies will investigate the anti-inflammation and microbiome modulation effects of PBM in an in vivo model of inflammatory bowel disease.
format Artículo científico
id pubmed_40543454
institution PubMed
language en
publishDate 2025
publisher Journal of photochemistry and photobiology. B, Biology
record_format pubmed
spellingShingle Therapeutic potential of wavelength-dependent photobiomodulation on gut inflammation in an in vitro intestinal model.
Kang, Myungji
Jo, Jihye
Shin, Hwarang
Kang, Hyun Wook
Humans
Caco-2 Cells
Low-Level Light Therapy
Lipopolysaccharides
Inflammation
Cytokines
NF-kappa B
Nitric Oxide
Lactobacillus
Coculture Techniques
Intestines
Gastrointestinal Microbiome
Nitric Oxide Synthase Type II
Therapeutic potential of wavelength-dependent photobiomodulation on gut inflammation in an in vitro intestinal model. Kang, Myungji Jo, Jihye Shin, Hwarang Kang, Hyun Wook Humans Caco-2 Cells Low-Level Light Therapy Lipopolysaccharides Inflammation Cytokines NF-kappa B Nitric Oxide Lactobacillus Coculture Techniques Intestines Gastrointestinal Microbiome Nitric Oxide Synthase Type II Recently, photobiomodulation (PBM) has emerged as a novel therapeutic approach for modulating the gut microbiome, offering potential for the regulation of intestinal inflammation. Although PBM has been primarily used for various clinical applications, recent studies suggest that its effects may extend to the regulation of microbial imbalances and chronic inflammation. The biological effects of PBM are wavelength-dependent, as the wavelength of light determines tissue penetration depth and cellular response. The current study aimed to compare the inflammation-modulatory effects of PBM at four different wavelengths (405, 532, 635, and 808 nm) and to elucidate the underlying molecular mechanisms of PBM in intestinal inflammation. An in vitro co-culture model consisting of Caco-2 cells and Lactobacillus was established to simulate the intestinal environment. Cellular inflammation was induced by lipopolysaccharide (LPS) stimulation, followed by wavelength-dependent PBM treatment at a dosage of 10 J/cm (100 mW/cm for 100 s, applied as a single irradiation). Among the wavelengths, 635 nm significantly reduced nitric oxide production and suppressed the expression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, and iNOS). Furthermore, western blot and qPCR analyses revealed that 635 nm PBM downregulated key signaling factors in the MAPK/NF-kB pathway, indicating a potential molecular mechanism for its anti-inflammatory effect. These findings suggest that PBM, particularly at 635 nm, may serve as an effective strategy for modulating intestinal inflammation. Further studies will investigate the anti-inflammation and microbiome modulation effects of PBM in an in vivo model of inflammatory bowel disease.
title Therapeutic potential of wavelength-dependent photobiomodulation on gut inflammation in an in vitro intestinal model.
topic Humans
Caco-2 Cells
Low-Level Light Therapy
Lipopolysaccharides
Inflammation
Cytokines
NF-kappa B
Nitric Oxide
Lactobacillus
Coculture Techniques
Intestines
Gastrointestinal Microbiome
Nitric Oxide Synthase Type II
url https://pubmed.ncbi.nlm.nih.gov/40543454/